Gender disparities in optimal lipid control among patients with coronary artery disease.
Coronary heart disease(CHD) is the leading cause of death worldwide in both men and women. Hypercholesterolemia is a major factor contributing to the incidence of CHD. Many lipid-lowering trials have shown statins to be effective medications for the primary and secondary prevention of CHD. Some studies have suggested that statins are as or more effective in women than in men. However, there is a substantial gender gap in lipid goal attainment with respect to primary care guidelines, as reported in observational studies. In this article, we attempt to explain gender differences in lipid control in individuals with or at risk of CHD in order to improve awareness of and narrow gaps in gender disparities in lipid management.
Cardiovascular Division, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College.
Chun-Yen
CY
Chen
Shao-Yuan
SY
Chuang
Ching-Chang
CC
Fang
Lien-Chi
LC
Huang
I-Chang
IC
Hsieh
Wen-Harn
WH
Pan
Hung-I
HI
Yeh
Chau-Chung
CC
Wu
Wei-Hsien
WH
Yin
Jaw-Wen
JW
Chen
D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000209:etiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D012737:Sex Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors